Institutional investors purchased a net $428.9 thousand shares of INSM during the quarter ended December 2015 and now own 92.44% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN STREET ADVISORS, INC. Bought 2.5 Thousand shares of Insmed Inc